What is Zacks Research's Estimate for EHC FY2025 Earnings?

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Encompass Health Corporation (NYSE:EHC - Free Report) - Analysts at Zacks Research raised their FY2025 EPS estimates for shares of Encompass Health in a research note issued to investors on Monday, August 18th. Zacks Research analyst Team now expects that the company will earn $5.21 per share for the year, up from their previous forecast of $4.94. The consensus estimate for Encompass Health's current full-year earnings is $4.80 per share. Zacks Research also issued estimates for Encompass Health's Q4 2025 earnings at $1.27 EPS, Q1 2026 earnings at $1.40 EPS, Q2 2026 earnings at $1.40 EPS, Q3 2026 earnings at $1.23 EPS, Q4 2026 earnings at $1.43 EPS, FY2026 earnings at $5.46 EPS, Q1 2027 earnings at $1.44 EPS, Q2 2027 earnings at $1.53 EPS and FY2027 earnings at $5.79 EPS.

A number of other analysts have also commented on the company. Stephens raised Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target on the stock in a research note on Thursday, June 5th. Truist Financial lifted their target price on shares of Encompass Health from $135.00 to $140.00 and gave the stock a "buy" rating in a research report on Thursday, August 14th. Wall Street Zen cut shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 6th. KeyCorp lifted their price target on shares of Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a report on Tuesday, May 27th. Finally, Royal Bank Of Canada boosted their price objective on shares of Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research note on Monday, April 28th. One equities research analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Buy" and an average price target of $134.00.

Encompass Health Price Performance

EHC stock traded down $0.1330 during midday trading on Tuesday, reaching $123.4070. 678,749 shares of the stock were exchanged, compared to its average volume of 899,979. Encompass Health has a 52 week low of $87.85 and a 52 week high of $124.67. The company has a fifty day moving average price of $116.34 and a 200 day moving average price of $110.12. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. The stock has a market capitalization of $12.43 billion, a PE ratio of 24.15, a P/E/G ratio of 2.16 and a beta of 0.86.

Encompass Health (NYSE:EHC - Get Free Report) last posted its earnings results on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, topping analysts' consensus estimates of $1.20 by $0.20. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The firm had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. During the same quarter in the previous year, the firm posted $1.11 earnings per share. The company's revenue was up 12.0% on a year-over-year basis. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS.

Encompass Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. This is a boost from Encompass Health's previous quarterly dividend of $0.17. The ex-dividend date is Wednesday, October 1st. Encompass Health's dividend payout ratio is currently 13.31%.

Institutional Trading of Encompass Health

A number of institutional investors have recently bought and sold shares of the company. WPG Advisers LLC bought a new position in shares of Encompass Health in the 1st quarter worth about $27,000. Colonial Trust Co SC bought a new stake in Encompass Health in the fourth quarter worth approximately $29,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in Encompass Health by 749.0% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company's stock valued at $42,000 after buying an additional 367 shares during the period. Newbridge Financial Services Group Inc. boosted its holdings in shares of Encompass Health by 112.5% during the 2nd quarter. Newbridge Financial Services Group Inc. now owns 425 shares of the company's stock worth $52,000 after buying an additional 225 shares in the last quarter. Finally, Transce3nd LLC acquired a new stake in shares of Encompass Health during the 4th quarter worth approximately $40,000. Institutional investors own 97.25% of the company's stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.